AVASTAMINE

Serial Number 86026633
Registration 4616084
710

Registration Progress

Application Filed
Aug 1, 2013
Under Examination
Approved for Publication
Jul 22, 2014
Published for Opposition
Jul 22, 2014
Registered
Oct 7, 2014

Trademark Image

AVASTAMINE

Basic Information

Serial Number
86026633
Registration Number
4616084
Filing Date
August 1, 2013
Registration Date
October 7, 2014
Published for Opposition
July 22, 2014
Cancellation Date
May 14, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
May 14, 2021

Rights Holder

Bio Health Solutions, LLC.

16
Address
101 Convention Center Drive Suite 700
Las Vegas, NV 89109

Ownership History

Bio Health Solutions, LLC.

Original Applicant
16
Las Vegas, NV

Bio Health Solutions, LLC.

Owner at Publication
16
Las Vegas, NV

Bio Health Solutions, LLC.

Original Registrant
16
Las Vegas, NV

USPTO Deadlines

Next Deadline
3351 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-10-07)
Due Date
October 07, 2034
Grace Period Ends
April 07, 2035

Application History

32 events
Date Code Type Description Documents
May 14, 2021 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Oct 7, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 18, 2015 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 7, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 22, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 22, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 2, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 16, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 10, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 10, 2014 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 10, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 10, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 10, 2014 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 6, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 6, 2014 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2014 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 30, 2014 ALIE A ASSIGNED TO LIE Loading...
May 16, 2014 CNFR R FINAL REFUSAL WRITTEN Loading...
May 16, 2014 GNFR O FINAL REFUSAL E-MAILED Loading...
May 16, 2014 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 16, 2014 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 14, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 13, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 13, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 19, 2013 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 19, 2013 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 19, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 15, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 10, 2013 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 9, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 5, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the word "Avastamine" in black with the letter "A" capitalized while the other letters are small, and with a light blue arc starting at the left side of the "A" and extending up and over the word and ending at the top of the letter "s", all on a white background.
Color Claim
The color(s) black, blue and white is/are claimed as a feature of the mark.
Translation
The English translation of "Avastamine" in the mark is "detection".
Pseudo Mark
AVASTA MINE

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"AVASTAMINE"